Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessBP (NYSE:BP) Analyst Actions and Market Speculation

BP (NYSE:BP) Analyst Actions and Market Speculation

Add to Favorite
Added to Favorite


Price Target Set by Jefferies: A price target of $29 was set for BP (NYSE:BP), indicating a slight overvaluation at its current trading price.
Downgrade to Hold: BP was downgraded from Buy to Hold by Jefferies, reflecting a cautious outlook on the stock.
Share Buybacks and Capital Return Strategy: BP’s strategy to return 30-40% of its operating cash flow to shareholders aims to provide a steady return on investment.

BP (NYSE:BP) is a major player in the global energy sector, known for its oil and gas production. The company is involved in various activities, including exploration, refining, and distribution of energy products. BP competes with other energy giants like ExxonMobil and Chevron. Recently, BP’s stock has been in the spotlight due to analyst actions and market speculation.

On May 19, 2025, Giacomo Romeo from Jefferies set a price target of $29 for BP. At that time, BP’s stock was trading at $29.76, indicating a price difference of approximately -2.55% from the target. This suggests that the stock was slightly overvalued according to Jefferies’ analysis. Additionally, BP was downgraded to Hold from Buy by Jefferies, as highlighted by TheFly.

BP’s shares saw a significant surge in May, driven by speculation about a potential takeover. Despite facing lower liquids realizations, BP reported decent earnings for the first quarter. The company maintained stable results in its oil production and continued to invest heavily in share buybacks, which can help support the stock price by reducing the number of shares available in the market.

BP has outlined a long-term capital framework, aiming to return 30-40% of its operating cash flow to shareholders. This strategy is designed to attract investors by providing a steady return on investment. BP’s market capitalization is approximately $77.76 billion, with a trading volume of 6,912,263 shares, reflecting its significant presence in the energy market.

Currently, BP is trading at $29.76, with a decrease of 1.16% and a change of $0.35. Today’s trading has seen a low of $29.51 and a high of $29.86. Over the past year, BP’s stock has reached a high of $37.60 and a low of $25.22, indicating some volatility in its stock price.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Trip.com Group Limited (NASDAQ:TCOM) Overview and Analyst Insights

Trip.com's consensus price target remains stable at $79.67, indicating...

Geron Corporation’s Capital Efficiency in the Biopharmaceutical Industry

Geron Corporation (NASDAQ:GERN) has a negative ROIC, indicating inefficient...

American Resources Corporation’s Upcoming Earnings and Financial Health

American Resources Corporation (NASDAQ:AREC) is a company involved in...

Invesco QQQ (NASDAQ:QQQ) Downgraded by Citigroup

Citigroup downgraded the Invesco QQQ to a "Reduce" rating,...